Terry Smith's position in Catalyst Pharmaceuticals is currently worth $47.1 Million. That's 0.20% of their equity portfolio (34th largest holding). The investor owns 1.72% of the outstanding Catalyst Pharmaceuticals stock. The investor's estimated purchase price is $48.5 Million, resulting in a loss of 2.9%.